A Risk Sciences International news item posted on December 12, 2016 and last updated on August 18, 2019

Because there is limited information available concerning the use of psychiatric drugs among the US adult population, Drs Moore and Mattison sought to characterize adult use of psychiatric drugs using publicly available, nationally representative data.  These analyses demonstrate that 1 of 6 US adults reported taking psychiatric drugs at least once during 2013, but with 2- to 3-fold differences by race/ethnicity, age, and sex.

http://www.nytimes.com/2016/12/12/health/one-in-6-american-adults-say-they-have-taken-psychiatric-drugs-report-says.html

http://www.cbsnews.com/news/psychiatric-drugs-study-reveals-widespread-use-women-men/

To read the journal article, click here.

 

 

 

 

More RSI News

Dr. Mattison chairs NAM report

July 24, 2020

Compounded medications prepared by pharmacists or physicians have been used extensively throughout history as a mainstay of therapeutics.  Over the past half-century – with the…

Country Foods Forum

March 1, 2020

Leading up to February 11 and 12, 2020, Risk Sciences International had the privilege of assisting Health Canada in its organization of the Country Foods…

Workshop on Evidence Integration December 5-6, 2019

November 11, 2019

Risk Sciences International is organizing a two day Workshop on Evidence Integration in support of human health risk assessment in collaboration with the McLaughlin Centre…

RSI wins 2019 Consulting Engineers of Ontario Award of Merit

June 14, 2019

Risk Sciences International (RSI), as members of a consulting team with Stantec, along with the Ontario First Nations Technical Services Corporation (OFNTSC), has won an Award of Merit from the…